HUMAN ISLETS FOR RESEARCH-We currently supply human islets to both the academic and corporate communities for their research related to diabetes. We pride ourselves on providing the highest quality islets, which we have been able to produce by using our proprietary media (PIM-Prodo Islet Media)
PRODO ISLET MEDIA (PIM)™- Our media is a cGMP product and has been designed to increase the viability and purity of the cells, from the initial recovery to the stage where the islets are ready for study and experiments. Our media is capable of long-term culturing, of up to 21 days, without loss of purity and viability.
OUR SERVICES-Prodo Labs is capable of performing many services on a contract basis. Some of these services include performing assays, animal isolations and islet testing.
RESEARCH-Working in conjunction with the Scharp-Lacy Research Institute, Prodo Labs is committed to performing research which could lead to a cure for diabetes. Led by Dr. David Scharp, MD, our company continues to break new ground in battling this debilitating disease.
PIM(R)™
PIM(R)™ is a new Prodo Labs islet specific media that is manufactured under cGMP conditions for tissue culture use in immediately recovering human islets following their processing and purification from pancreases. It is designed for the first 48 hours of tissue culture at 37oC. It accelerates the recovery of the islets as demonstrated by rapid rounding up with increased glucose responsiveness, insulin content, and suitability for implantation. It currently is designed to be used with 5% Human AB Serum that is pretested for islet suitability. It does not contain any animal proteins or growth factors and has a glucose concentration of 5.8 mM.
Click Here for complete technical notes.
Prodo Labs provides high quality human islets for research as its primary service business by direct contracts with biotechnology and pharmaceutical companies utilizing them for in vitro and in vivo testing in the development of new drugs for diabetes or in the development of new insulin-producing cells for future transplants.
